MAIA Biotechnology, Inc. director Stan Smith buys 100,000 shares worth $100,000
An open-market purchase between Nov 13 and Nov 16, reported to the SEC on Nov 17.
Insider buying at MAIA Biotechnology, Inc.: Stan Smith, a director, added 100,000 shares between Nov 13 and Nov 16 for about $100,000, at an average of $1.00 a share, a Form 4 filed on Nov 17 shows.
The filing reports the shares as held indirectly, for example through a trust or a fund. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 1,619,178 shares held. It is the seventh insider purchase at MAIA Biotechnology, Inc. reported in the last 90 days.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | MAIA Biotechnology, Inc. (MAIA) |
|---|---|
| Insider | Stan Smith |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 100,000 |
| Average price | $1.00 |
| Value | $100,000 |
| Trade dates | Nov 13 to Nov 16, 2026 |
| Filed with the SEC | Nov 17, 2026, 4:07 PM ET |
| Shares held after | 1,619,178 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See the full details of this insider trade
See earlier insider stories on MAIA Biotechnology, Inc. · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.